#ResearchUpdate – Dr. Reddy’s Labs indicated medium term aspiration to achieve double digit sales growth and
25% EBITDA margin.
Read more: http://ow.ly/LHf750JFn1MDisclaimer: http://ow.ly/i8rv50JFn1N #ResearchUpdate
Rohtak - 124001
Sector 2 & 3P
On our website, we use services (including from third-party providers) that help us to improve our online presence (optimization of website) and to display content that is geared to their interests. We need your consent before being able to use these services.